Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,445 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 0–15%
Healthcare Services Mid (2.2bn) -1–5 $10M–$100M 50%+ 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 15–50%
Healthcare Services Mid (2.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (2.2bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Mid (2.2bn) 1–5 $100K–$1M 0–15% 0–15%
US 89Bio Inc (ETNB)
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 15–50%
FR Orpea SA (ORP)
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 15–50%
BE Fagron NV (FAGR)
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 15–50%
CH Idorsia Ltd (IDIA)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
SE AddLife AB (ALIF-B)
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -< $100K -0–15% 50%+
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 0–15%
Healthcare Services Mid (2.0bn) 0 No activity — 15–50%
US Absci Corp (ABSI)
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 0–15%
Healthcare Services Mid (2.0bn) 0 No activity — 0–15%
Healthcare Services Mid (2.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 50%+
Healthcare Services Mid (2.0bn) 1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 No activity — 0–15%
US Quidel Corp (QDEL)
Healthcare Services Small (2.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Small (1.9bn) -1–5 -$10M–$100M -0–15% 0–15%
GB Genus PLC (GNS)
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 0–15%
Healthcare Services Small (1.9bn) 0 No activity — 0–15%
Healthcare Services Small (1.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) 1–5 < $100K 0–15% 15–50%
FR Emeis SA (EMEIS)
Healthcare Services Small (1.9bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Small (1.9bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Azenta Inc (AZTA)
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Small (1.8bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) -6–10 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Small (1.7bn) -6–10 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$10M–$100M -0–15% 50%+
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Healthcare Services Small (1.7bn) -1–5 -$10M–$100M -0–15% 50%+
Healthcare Services Small (1.7bn) 1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Small (1.6bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals & Medical Research Small (1.6bn) 0 -$10M–$100M -0–15% 15–50%
Healthcare Services Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Loading...